KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Treasury Shares (2016 - 2025)

Cme (CME) has disclosed Treasury Shares for 15 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares fell 4.67% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 million, a 4.67% decrease, with the full-year FY2025 number at $1.0 million, down 4.67% from a year prior.
  • Treasury Shares was $1.0 million for Q4 2025 at Cme, down from $1.1 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.1 million in Q4 2022 to a low of $1.0 million in Q4 2025.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: decreased 11.8% in 2021, then increased 0.22% in 2022.
  • Cme's Treasury Shares stood at $1.1 million in 2021, then rose by 0.22% to $1.1 million in 2022, then decreased by 1.57% to $1.1 million in 2023, then decreased by 1.14% to $1.1 million in 2024, then decreased by 4.67% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Treasury Shares are $1.0 million (Q4 2025), $1.1 million (Q4 2024), and $1.1 million (Q4 2023).